209 related articles for article (PubMed ID: 21904776)
1. A new membrane re-anchored protein originating from GPC3 against hepatoma cells HepG2.
Yang D; Yang J; Lu F; Li C; Yang J; Liang J
Mol Med Rep; 2011; 4(6):1067-73. PubMed ID: 21904776
[TBL] [Abstract][Full Text] [Related]
2. [Expression and localization of strong epitope hAFP(542-550); on eukaryotic cytoplasmic membrane].
Yang DY; Li CH; Lan F; Zhang YQ; Lu FG; Yang ZR; Huang LQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jul; 25(7):592-5, 599. PubMed ID: 19737475
[TBL] [Abstract][Full Text] [Related]
3. GPC3 fused to an alpha epitope of HBsAg acts as an immune target against hepatocellular carcinoma associated with hepatitis B virus.
Yang JW; Yang DY; Lu FG; Li CH; Chen H; Xie N; Zhao X
Hepatobiliary Pancreat Dis Int; 2011 Apr; 10(2):164-70. PubMed ID: 21459723
[TBL] [Abstract][Full Text] [Related]
4. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080
[TBL] [Abstract][Full Text] [Related]
5. [Recombinant plasmid pEGFP-AFP-TK delivered by nano-magnetic fluids targeting killed AFP positive HepG2 cells in vitro].
Luo Y; Zhang YD; Peng J; Yan HX; Xue D; Wu K; Zhou L; Hang SW; Zhao JF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 May; 25(5):437-9. PubMed ID: 19426602
[TBL] [Abstract][Full Text] [Related]
6. [Construction of eukaryotic expression vector for EBF3 and EGFP fusion protein and its expression in HepG2 cells].
Mao LP; Wang HM; Wang YG; Wang XY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Oct; 24(10):954-7. PubMed ID: 18845077
[TBL] [Abstract][Full Text] [Related]
7. Glypican3 in genetically modified human monocyte-derived dendritic cells induced specific cytotoxity against glypican3 overexpressing human hepatocellular carcinoma cells in vitro.
Guo DW; Zhang SY; Hou XZ; Li HW; Jiang XF; Sun WY; We YT; Liang J
Saudi Med J; 2008 Sep; 29(9):1235-40. PubMed ID: 18813403
[TBL] [Abstract][Full Text] [Related]
8. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
9. Effects of AFP gene silencing on apoptosis and proliferation of a hepatocellular carcinoma cell line.
Zhang L; He T; Cui H; Wang Y; Huang C; Han F
Discov Med; 2012 Aug; 14(75):115-24. PubMed ID: 22935208
[TBL] [Abstract][Full Text] [Related]
10. [Killing effect of PNP/MeP-dR suicide gene system driven by an AFP promoter AF0.3 on AFP-positive hepatoma cells].
Cai XK; Zhou JL; Zhou HJ; Zhang L; Wu JH; Lin JS
Ai Zheng; 2006 Nov; 25(11):1334-9. PubMed ID: 17094897
[TBL] [Abstract][Full Text] [Related]
11. [Establishment of AFP promoter operated murine IL-1beta recombinant vector and its expression in H22 cells].
Li QC; Liang SJ; Wang XJ; Liu YY; Wang HQ; Zhang SH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jul; 25(7):603-5. PubMed ID: 19737477
[TBL] [Abstract][Full Text] [Related]
12. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
13. Effect of recombinant plasmid pEGFP-AFP-hTNF on liver cancer cells (HepG2 Cells) in vitro when delivered by PEG-PEI/Fe₃O₄ nanomagnetic fluid.
Zhuang B; Zhang Y; Peng J; Zhang H; Hu T; Zeng J; Li Y
J Formos Med Assoc; 2011 May; 110(5):326-35. PubMed ID: 21621154
[TBL] [Abstract][Full Text] [Related]
14. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
[TBL] [Abstract][Full Text] [Related]
15. Alpha-fetoprotein acts as a novel signal molecule and mediates transcription of Fn14 in human hepatocellular carcinoma.
Wang S; Jiang W; Chen X; Zhang C; Li H; Hou W; Liu Z; McNutt MA; Lu F; Li G
J Hepatol; 2012 Aug; 57(2):322-9. PubMed ID: 22521346
[TBL] [Abstract][Full Text] [Related]
16. [Effect of glypican-3 on the proliferation of human hepatoma cell line MHCC97-L in vitro].
QIN RZ; LIU FY; CHEN B; XIE JM; YANG Y; ZHEGN DY; LUO RC
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):448-52. PubMed ID: 21421480
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2].
Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q
Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759
[TBL] [Abstract][Full Text] [Related]
18. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852
[TBL] [Abstract][Full Text] [Related]
19. Effects of AFP gene silencing on Survivin mRNA expression inhibition in HepG2 cells.
Fang ZL; Fang N; Han XN; Huang G; Fu XJ; Xie GS; Wang NR; Xiong JP
Genet Mol Res; 2015 Apr; 14(2):3184-90. PubMed ID: 25966084
[TBL] [Abstract][Full Text] [Related]
20. [Construction and study of replication-defective adenovirus targeting hepatocarcinoma].
Xu DY; Du ZY; Wang Y; Chen HH; Xu YJ; Lu YL
Ai Zheng; 2006 Jul; 25(7):798-804. PubMed ID: 16831267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
